Company reported a 4.5% increase in comparable revenue to €10.27 billion for the six months LONDON: Coca-Cola Europacific Partners (CCEP) announced solid results for the first half of 2025, reaffirming its full-year profit and cash guidance despite a volatile global economic environment. The company, which bottles and distributes Coca-Cola products across Europe and the Asia-Pacific…
IMI delivers 5% profit growth, reaffirming full-year earnings outlook LONDON: IMI Plc reported a resilient financial performance for the first half of 2025, with organic revenue rising 2% and organic adjusted operating profit up 5%, despite foreign exchange headwinds that led to a 1% decline in statutory revenue. The company’s adjusted operating margin improved by…
Company posted a 15% increase in consolidated revenue, reaching €3.6 billion, while recurring EBITDA rose 13% to €319 million PARIS: Technip Energies reported strong unaudited financial results for the first half of 2025, underscoring its continued momentum and strategic progress in energy infrastructure and decarbonization. The company posted a 15% year-over-year increase in consolidated revenue,…
Adjusted operating profit fell 17.5% year-over-year to £55.1 million LONDON: Bodycote plc reported a 7.5% decline in group revenue to £369.0 million for the first half of 2025, citing weak conditions in automotive and industrial markets. Despite this, the company maintained its full-year outlook, highlighting progress in strategic initiatives and signs of sequential growth across…
LONDON: NatWest Bank Group (NWB Group) on Friday reported an attributable profit of £1.85 billion for the first half of 2025, as income rose and operating costs remained stable. The group’s Common Equity Tier 1 (CET1) ratio stood at 11.3% for NWB Plc, down slightly from year-end 2024. Total income surged 8% year-over-year to £6.36…
LONDON: Diaceutics PLC (AIM: DXRX), a technology provider for pharmaceutical and biotech companies, announced strong first-half revenue growth driven by increased demand for its precision medicine commercialization services. Revenue rose 22% on a constant currency basis to £14.6 million ($18.9 million) in H1 2025, marking a three-year compound annual growth rate of 25%. Recurring revenue…
LONDON: MONY Group plc delivered resilient interim results for the six months ended 30 June 2025, with CEO Peter Duffy citing strategic momentum and platform agility as key drivers amid macroeconomic pressure in select verticals. Group revenue edged up 1% year-over-year to £225.3 million, while adjusted EBITDA rose 2% to £75.1 million, supported by cost…